Impact of End‐Stage Renal Disease on Outcomes of Rotational Atherectomy‐Assisted Percutaneous Coronary Interventions: Insights From a National Inpatient Cohort
Catheterization and Cardiovascular Interventions · 2026-07 · 108 (1) · 130-136
DOI: 10.1002/ccd.70636 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, published online on 2026-04-22. Written by Rutvi Amin and 6 co-authors. Institution: Overland Park Regional Medical Center, HCA Midwest Health, Overland Park, Kansas, USA. Major MEDLINE topics: Atherectomy, Coronary, Kidney Failure, Chronic, Coronary Artery Disease, Vascular Calcification. Cited 1 times so far (Crossref); 29 references.
Abstract (original language)
Background
Rotational atherectomy (RA) has become one of the most popular percutaneous coronary intervention (PCI) modalities for the management of patients with calcified coronary artery disease. However, the impact of end‐stage renal disease (ESRD) on the post‐RA outcomes is not fully determined.
Methods
We implemented the National Inpatient Sample (NIS) data of a propensity‐score matched sample of adult cases who underwent RA from 2016 to 2021 to retrospectively compare their in‐hospital outcomes according to the ESRD status. Multivariable regression models explored their complications.
Results
A 1:1 matched cohort of 11,555 with underlying ESRD and 11,555 without undergoing RA was generated. In terms of post‐RA outcomes and complications, multivariate regression revealed increased adjusted odds ratios (aOR) for death (aOR: 1.514; 95% CI: 1.308–1.752; p < 0.001), major bleeding (aOR: 3.845; 95% CI: 3.595–4.113; p < 0.001), postoperative sepsis (aOR: 1.819; 95% CI: 1.517–2.183; p < 0.001), cardiac arrest (aOR: 1.169; 95% CI: 1.015–1.347; p = 0.03), cardiogenic shock (aOR: 1.212; 95% CI: 1.084–1.354; p < 0.001), and vasopressor use (aOR: 1.511; 95% CI: 1.249–1.828; p < 0.001) in the ESRD cohort.
Conclusion
The in‐hospital morbimortality after RA differs significantly in patients with and without ESRD. Notably, this comorbidity is independently associated with poorer outcomes and complications post RA. Therefore, the ESRD status should be considered for preoperative stratification of patients undergoing RA‐guided PCI.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Overland Park Regional Medical Center, HCA Midwest Health, Overland Park, Kansas, USA.
- Faculty of Medicine, University of Health Sciences, Algiers, Algeria.
- Trinity Health Oakland/Wayne State University, Pontiac, Michigan, USA.
- Trinity Health Livonia Hospital, Novi, Michigan, USA.
- GGSMCH, FARIDKOT, Punjab, India.
- Independent Researcher, Las Vegas, Nevada, USA.
ORCID profiles: Rutvi Amin, Yehya Khlidj, Fathima Shehnaz Ayoobkhan
Cite
APA
Amin, R., Khlidj, Y., Ayoobkhan, F. S., Johal, P., Singla, R., Ramphul, K., & Mittal, V. (2026). Impact of End‐Stage Renal Disease on Outcomes of Rotational Atherectomy‐Assisted Percutaneous Coronary Interventions: Insights From a National Inpatient Cohort. Catheterization and Cardiovascular Interventions, 108(1), 130-136. https://doi.org/10.1002/ccd.70636
Vancouver
Amin R, Khlidj Y, Ayoobkhan FS, Johal P, Singla R, Ramphul K, et al. Impact of End‐Stage Renal Disease on Outcomes of Rotational Atherectomy‐Assisted Percutaneous Coronary Interventions: Insights From a National Inpatient Cohort. Catheterization and Cardiovascular Interventions. 2026;108(1):130-136. doi:10.1002/ccd.70636
BibTeX
@article{Amin2026,
author = {Amin, Rutvi and Khlidj, Yehya and Ayoobkhan, Fathima Shehnaz and Johal, Parampreet and Singla, Rahul and Ramphul, Kamleshun and Mittal, Vivek},
title = {Impact of End‐Stage Renal Disease on Outcomes of Rotational Atherectomy‐Assisted Percutaneous Coronary Interventions: Insights From a National Inpatient Cohort},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {108},
number = {1},
pages = {130--136},
doi = {10.1002/ccd.70636}
}
EUVIMED